Retractable Technologies Total Non-Operating Income/Expense 2010-2024 | RVP

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Retractable Technologies total non-operating income/expense from 2010 to 2024. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.

Retractable Technologies Total Non-Operating Income/Expense 2010-2024 | RVP

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Retractable Technologies total non-operating income/expense from 2010 to 2024. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.

Related Stocks
Company Name	Market Cap
Becton Dickinson (BDX)	$67.8B
McKesson (MCK)	$65.9B
Cardinal Health (CAH)	$26.8B
West Pharmaceutical Services (WST)	$22.6B
Cooper (COO)	$22.1B
Align Technology (ALGN)	$19.2B
Labcorp (LH)	$18.9B
Henry Schein (HSIC)	$9.2B
Merit Medical Systems (MMSI)	$5.8B
DENTSPLY SIRONA (XRAY)	$5.5B
CONMED (CNMD)	$2.3B
Patterson (PDCO)	$2B
STAAR Surgical (STAA)	$1.6B
Lifevantage (LFVN)	$129M
Pro-Dex (PDEX)	$93M